Efficient procedures for the synthesis of 21-24-and 28-31-membered macrocyclic azino diesters and dihydrazido diesters were developed starting from L-menthol, Δ 3 -carene, (+)-α-pinene, tetrahydropyran, and 4-methyltetrahydropyran. The key steps in these syntheses were consecutive [2 + 1]-and [1 + 1]-condensations. The 31-membered dihydrazido diester exhibited strong antibacterial activity.* For preliminary communications, see [1][2][3][4].We recently reported [5] on the synthesis of eight potentially useful 15-, 17-, 20-, and 22-25-membered macrocycles having an azine or hydrazide fragment starting from L-menthol (I), tetrahydropyran (II), and 4-methyltetrahydropyran (III) via consecutive Tishchenko reaction and [1 + 1]-condensation.We now propose efficient procedures for the transformation of compounds I-III, as well as of accessible monoterpenes, Δ 3 -carene (IV) and (+)-α-pinene (V), into macrocyclic azino diesters XXI-XXIX and dihydrazido diesters XXX-XXXIX. All these procedures are based on initial transformation of compounds I-V into the corresponding hydroxy ketones: (6R)-8-hydroxy-2,6-dimethyloctan-3-one (VI). The subsequent [2 + 1]-condensation of compounds VI-X with glutaric and adipic acid dichlorides afforded open-chain diesters XI-XX containing two fragments of ketones VI-X as alcohol residues. Dioxo diesters XI-XX were then subjected to cyclization via [1 + 1]-condensation with hydrazine hydrate and glutaric acid dihydrazide in strongly dilute dioxane solution at room temperature to obtain azino diesters XXI-XXIX and dihydrazido diesters XXX-XXXIX, respectively (Schemes 1-4). The purity of intermediate compounds XI-XX and target macroheterocycles XXI-XXXIX was checked by HPLC, and their structure was confirmed by IR, 1 H and 13 C NMR, and mass spectra.The synthesized compounds were tested for biological activity at the Noncontagious Internal Diseases, Clinical Diagnostics, and Pharmacology Department, Bashkir State Agrarian University [4]; it was found that 31-membered macrocyclic dihydrazido diester XXXIII showed in vitro and in vivo antibacterial activity comparable with the activity of Erythromycin.
EXPERIMENTALThe IR spectra were recorded on a UR-20 spectrometer from thin films. The NMR spectra were measured on a Bruker AM-300 spectrometer at 300.13 MHz for 1 H and 75.47 MHz for 13 C using CDCl 3 as solvent and tetramethylsilane as internal reference. Chromatographic analysis was performed on Chrom-5 [1.2-m column, stationary phase 5% of SE-30 on Chromaton N-AW-DMCS (0.16-0.20 mm), oven temperature 50-300°C] and Chrom-41 instruments [2.4-m column, stationary phase PEG-6000, oven temperature 50-200°C]; carrier gas helium. HPLC analyses were obtained on a Shimadzu LC-20AD liquid chromatograph equipped with an SPD M20A diode matrix detector [250 × 4.6-mm Phenomenex column; sorbent Luna C18, grain size 5 μm; eluent water-acetonitrile, flow rate 1 ml/min; analytical wavelength 215 nm]. Silica gel, 70-230 μm